Page 27 - Core Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

gammaCore TM (nVNS) is the first non-invasive, hand-held medical therapy applied at the neck as an adjunctive therapy to treat migraine and cluster headache through the utilization of a mild electrical stimulation to the vagus nerve that passes through the skin. Designed as a portable, easy-to-use technology, gammaCore can be self-administered by patients, as needed, without the potential side effects associated with commonly prescribed drugs. When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers, which may lead to a reduction of pain in p...

Home / Top News / electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients nVNS decreases certain biomarkers associated with the severity of COVID-19 through five days of treatment ROCKAWAY, NJ, April 08, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the top-line results from the SAVIOR-1 study...

Share: Amid the vaccine roll out, 97,309 new cases of COVID-19 have been reported to the CDC. Peter Staats, M.D. Chief Medical Officer of electroCore, Inc. (NASDAQ:ECOR), outlines common COVID-19 symptoms and at-home steps that can be discussed with health care providers to reduce symptoms. At-home steps to reduce COVID-19 symptoms: Confusion and Brain Fog: Although brain fog is not a true medical condition, it is a common symptom for many COVID-19 patients. Confusion and brain fog can be very frustrating and cause forgetfulness, cognitive decline, memory problems, inability to focus, hazines...

April 01, 2021 4:08 PM

Following the market opening Monday, the Dow traded up 1.91% to 31,522.98 while the NASDAQ rose 1.72% to 13,419.71. The S&P also rose, gaining 1.75% to ...